In conclusion, CUD003, a novel synthetic Cur derivative, ameliorates LPS-induced endothelial dysfunction primarily by inhibiting inflammation and oxidative stress, as demonstrated by reduced TNF-α and COX-2 expression, along with decreased O2− production and lipid peroxidation. The gene discussed is PTGS2; the disease is endothelial dysfunction.